Neonc Technologies (NASDAQ:NTHI) CEO Buys $95,100.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 30,000 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The stock was bought at an average price of $3.17 per share, for a total transaction of $95,100.00. Following the purchase, the chief executive officer directly owned 3,213,000 shares in the company, valued at $10,185,210. The trade was a 0.94% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Neonc Technologies Stock Up 3.4%

NTHI stock opened at $4.52 on Thursday. The business has a 50 day moving average of $3.30 and a 200 day moving average of $5.31. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $12.00.

Neonc Technologies (NASDAQ:NTHI) last released its earnings results on Thursday, November 5th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on NTHI. Wall Street Zen raised Neonc Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, November 7th. Zacks Research raised shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 5th. Weiss Ratings downgraded shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, October 21st. Roth Capital assumed coverage on shares of Neonc Technologies in a research note on Thursday, September 24th. They set a “buy” rating for the company. Finally, BTIG Research restated a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research note on Tuesday, September 8th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Neonc Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Hedge Funds Weigh In On Neonc Technologies

Hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE boosted its stake in Neonc Technologies by 5.0% during the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after purchasing an additional 11,108 shares during the last quarter. Westmount Partners LLC raised its stake in shares of Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after purchasing an additional 153,858 shares during the last quarter. BlackRock Inc. purchased a new position in shares of Neonc Technologies in the second quarter worth $815,000. Finally, Global Retirement Partners LLC purchased a new position in shares of Neonc Technologies in the second quarter worth $126,000.

Neonc Technologies Company Profile

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.